July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Involvement of eicosanoid in pterygium
Author Affiliations & Notes
  • Aihua Hou
    Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore, Singapore
  • Yohannes Abere Ambaw
    Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  • Ming Yi Gan
    Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore, Singapore
  • Markus Wenk
    Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  • Louis Tong
    Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore, Singapore
    Singapore Nationa Eye Center, Singapore
  • Footnotes
    Commercial Relationships   Aihua Hou, None; Yohannes Ambaw, None; Ming Yi Gan, None; Markus Wenk, None; Louis Tong, None
  • Footnotes
    Support  The fund supporting study in part is NMRC/CSA/017/2017
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4706. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aihua Hou, Yohannes Abere Ambaw, Ming Yi Gan, Markus Wenk, Louis Tong; Involvement of eicosanoid in pterygium. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4706.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pterygium is a benign outgrowth from conjunctiva to cornea, characterized by abnormal cell proliferation and increased inflammation. Eicosanoids are locally acting bioactive signaling lipids which regulate a diverse set of homeostatic and inflammatory processes, involved in numerous diseases. Previous study compared lipidomics of pterygium and donor cornea-scleral grafts, but this did not extend to small polar lipids like the eicosanoids.In this study, we compared eicosanoids between pterygium and conjunctiva tissues from the same patients.

Methods : Eleven pairs of pterygium and uninvolved conjunctiva tissues from the same eyes were harvested. Eicosanoids were extracted after homogenization through solid phase extraction (SPE) and analyzed using liquid chromatography mass spectrometry (LCMS). Sixty different eicosanoids were quantified using known internal standards and concentration normalized to 1 mg of total protein.

Results : The levels of three eicosanoids were significantly dysregulated in pterygium prostaglandin (PGF2α), 15-hydroxyeicosatetraenoic acid (15-HETrE) and 15-oxo eicosatetraenoic (15-oxoETE). PGF2αlevel in pterygium was 1.3-fold higher as compared to conjunctiva; 15-HETrE and 15-oxo ETE levels were 2-fold higher as compared to control tissues. One eicosanoid, 5,6- EET, was 1.5-fold reduced in pterygium when compared to control.

Conclusions : Inflammation is the hallmark of pterygiumand specific eicosanoids may be involved in the process viaactions on immune cells or resolution of inflammation.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×